India, April 28 -- image credit- freepik

Akums Drugs & Pharmaceuticals, a Delhi-based Contract Development and Manufacturing Organization (CDMO), has announced the launch of Aztreonam-Avibactam Injection, an advanced antibiotic therapy aimed at treating multidrug-resistant gram-negative bacterial infections.

The therapy is designed for severe and life-threatening infections that show limited or no response to conventional antibiotics, particularly in intensive care settings.

"The rise of antimicrobial resistance has significantly reduced the effectiveness of conventional therapies," said Sanjeev Jain, Managing Director, Akums. "Aztreonam-Avibactam represents an important advancement in addressing infections caused by highly resistant p...